Literature DB >> 26606597

Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential.

Chen Li, Yanping Gao, Kai Zhang, Jing Chen, Siqi Han, Bing Feng, Rui Wang, Longbang Chen.   

Abstract

MicroRNAs (miRNAs) are a recently discovered class of endogenous, small (about 22 nucleotides) non-coding RNAs, which play important roles in cancer development and progression. Emerging evidence shows that microRNAs exert their regulatory effects by directly binding to the 3'- untranslated regions (UTRs) of their target genes. MicroRNA-100 (miR-100) is aberrantly expressed and functions in many human cancers by regulating multiple cell processes, such as cell cycle, proliferation, differentiation, migration, invasion and apoptosis, via post-transcriptionally regulating various target genes. A better understanding of the molecular mechanisms involved in miR-100-mediated tumor progression will provide an opportunity for exploring novel miR-100-based targeted therapies for human cancers. This review aims to summarize the recently published literature on the roles of miR-100 in regulating tumorigenesis, and explore its potential clinical applications for cancer diagnosis, prognosis and clinical treatment.
© 2015 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26606597     DOI: 10.1159/000438572

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  26 in total

1.  Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.

Authors:  Uday K Sukumar; Rajendran J C Bose; Meenakshi Malhotra; Husam A Babikir; Rayhaneh Afjei; Elise Robinson; Yitian Zeng; Edwin Chang; Frezghi Habte; Robert Sinclair; Sanjiv S Gambhir; Tarik F Massoud; Ramasamy Paulmurugan
Journal:  Biomaterials       Date:  2019-07-12       Impact factor: 12.479

2.  Differentially expressed miR-20, miR-21, miR-100, miR-125a and miR-146a as a potential biomarker for prostate cancer.

Authors:  Mohan Damodaran; Mohanapriya Chinambedu Dandapani; S VenkatRamanan; Ilangovan Ramachandran; Vettriselvi Venkatesan
Journal:  Mol Biol Rep       Date:  2021-05-04       Impact factor: 2.316

Review 3.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

4.  Altered miRNA expression in aniline-mediated cell cycle progression in rat spleen.

Authors:  Gangduo Wang; Jianling Wang; M Firoze Khan
Journal:  Toxicol Mech Methods       Date:  2017-06-06       Impact factor: 2.987

5.  Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.

Authors:  Anda J Stroese; Hansjoerg Ullerich; Gabriele Koehler; Verena Raetzel; Norbert Senninger; Sameer A Dhayat
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-17       Impact factor: 4.553

Review 6.  The protean world of non-coding RNAs in glioblastoma.

Authors:  Ramasamy Paulmurugan; Meenakshi Malhotra; Tarik F Massoud
Journal:  J Mol Med (Berl)       Date:  2019-05-25       Impact factor: 4.599

7.  The Emerging Field of Noncoding RNAs and Their Importance in Pediatric Diseases.

Authors:  Rui Zhou; Piyush Joshi; Keisuke Katsushima; Weihong Liang; Wei Liu; Neil A Goldenberg; George Dover; Ranjan J Perera
Journal:  J Pediatr       Date:  2020-06       Impact factor: 4.406

Review 8.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

9.  MicroRNA Ratios Distinguish Melanomas from Nevi.

Authors:  Rodrigo Torres; Ursula E Lang; Miroslav Hejna; Samuel J Shelton; Nancy M Joseph; A Hunter Shain; Iwei Yeh; Maria L Wei; Michael C Oldham; Boris C Bastian; Robert L Judson-Torres
Journal:  J Invest Dermatol       Date:  2019-09-30       Impact factor: 8.551

10.  MiR-100-5p regulates cardiac hypertrophy through activation of autophagy by targeting mTOR.

Authors:  Junyi Zeng; Liang Wang; Jianqing Zhao; Zeqi Zheng; Jingtian Peng; Wan Zhang; Tong Wen; Jungang Nie; Lu Ding; Dasong Yi
Journal:  Hum Cell       Date:  2021-06-17       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.